Travere Therapeutics
TVTX
TVTX
81 hedge funds and large institutions have $735M invested in Travere Therapeutics in 2015 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 39 increasing their positions, 14 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
100% more funds holding in top 10
Funds holding in top 10: 3 → 6 (+3)
25% more funds holding
Funds holding: 65 → 81 (+16)
Holders
81
Holding in Top 10
6
Calls
$53.3M
Puts
$11.6M
Top Buyers
| 1 | +$29M | |
| 2 | +$22.5M | |
| 3 | +$20.2M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$17.9M |
| 5 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
+$16.8M |
Top Sellers
| 1 | -$23M | |
| 2 | -$10.1M | |
| 3 | -$5.17M | |
| 4 |
SAM
Senzar Asset Management
New York
|
-$3.76M |
| 5 |
VAM
Visium Asset Management
New York
|
-$2.84M |